HEALTHJun 2 · 00:31 UTCCROSSCUT SEATTLECascade PBS Staff

Promising pancreatic cancer treatment doubles survival rates

An experimental drug for pancreatic cancer, taken once daily, has shown promising results in slowing cancer progression and extending patient survival. Dr. Rachna Shroff from the University of Arizona Comprehensive Cancer Center discusses the treatment's potential.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Rachna ShroffpersonUniversity of Arizona Comprehensive Cancer Centerorganizationpancreatic cancertopicexperimental drugtopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 15 · 03:32 UTC
WATCH: How a new drug could lengthen lives of pancreatic cancer patients
HEALTHJun 1 · 13:52 UTC
Drug nearly doubles survival rate for some pancreatic cancer patients, study finds
HEALTHJun 1 · 18:45 UTC
'Game changer' experimental drug doubles survival time for pancreatic cancer, trial shows
HEALTHMay 6 · 22:34 UTC
Experimental new drug could revolutionize pancreatic cancer treatment, doctors say
HEALTHApr 30 · 14:59 UTC
High hopes for new pancreatic cancer therapies
HEALTHJun 2 · 00:03 UTC
What makes promising pancreatic cancer drug different from chemotherapy?